Table 3. Top 20 pathways identified by Ingenuity Pathway Analysis.
Ingenuity Canonical Pathways | P-value | Genes |
---|---|---|
Granulocyte Adhesion and Diapedesis | 4.37E-09 | CXCL3, IL1A, CCL4, FPR2, CCL3L1/CCL3L3, MMP13, IL1B, FPR1 |
Atherosclerosis Signaling | 9.55E-09 | IL1A, CD40, CSF1, LPL, MMP13, IL1B, S100A8 |
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis | 2.04E-08 | TLR2, IL1A, CSF1, MMP13, OSM, IL1B, IRAK3, TCF7L2, TRAF1 |
Communication between Innate and Adaptive Immune Cells | 5.13E-08 | TLR2, IL1A, CCL4, CD40, CCL3L1/CCL3L3, IL1B |
Hepatic Fibrosis / Hepatic Stellate Cell Activation | 6.46E-07 | CXCL3, IL1A, CD40, CSF1, MMP13, IL1B |
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis | 1.35E-06 | TLR2, IL1A, CD40, CSF1, IL1B |
NF-ΰB Signaling | 2.29E-06 | TLR2, IL1A, TNIP1, CD40, IL1B, IRAK3 |
Agranulocyte Adhesion and Diapedesis | 3.39E-06 | CXCL3, IL1A, CCL4, CCL3L1/CCL3L3, MMP13, IL1B |
LXR/RXR Activation | 7.41E-06 | IL1A, LPL, IL1B, S100A8, ARG2 |
Differential Regulation of Cytokine Production in Intestinal Epithelial Cells by IL-17A and IL-17F | 1.82E-05 | IL1A, CCL4, IL1B |
TREM1 Signaling | 2.40E-05 | TLR2, CXCL3, CD40, IL1B |
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis | 1.29E-04 | IL1A, CSF1, MMP13, IL1B, TCF7L2 |
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza | 1.32E-04 | IL1A, CCL4, IL1B |
Role of IL-17F in Allergic Inflammatory Airway Diseases | 1.41E-04 | CCL4, MMP13, IL1B |
Hepatic Cholestasis | 2.63E-04 | IL1A, SLCO3A1, IL1B, IRAK3 |
Toll-like Receptor Signaling | 2.69E-04 | TLR2, IRAK3, TRAF1 |
Role of IL-17A in Psoriasis | 3.80E-04 | CXCL3, S100A8 |
IL-10 Signaling | 4.79E-04 | IL1A, IL1B, ARG2 |
Acute Phase Response Signaling | 5.50E-04 | IL1A, Saa3, OSM, IL1B |
Dendritic Cell Maturation | 6.76E-04 | TLR2, IL1A, CD40, IL1B |
From the 48 differentially expressed genes in response to S. japonicum soluble egg antigen in the ex vivo native mouse liver model over 48 hours.